HDAC2 and colorectal carcinoma: Research by Guan et al. found that HDAC2 overexpression in CRC epigenetically silences NLRP3 by removing H3K27 acetylation from its promoter, reducing chromatin accessibility and blocking recruitment of the BRD4-phosphorylated P65 complex [63].